Apolipoprotein E and apolipoprotein B genotypes and risk for spina bifida

Teratology

Volumn 66, Issue 5, 2002, Pages 257-259

  Volcik, Kelly A ^a   Zhu, Huiping ^a   Shaw, Gary M ^b   Lammer, Edward J ^c   Finnell, Richard H ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b March of Dimes Birth Defects Foundation   (United States)

^c CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL;

ARTICLE; BRAIN DEVELOPMENT; CHOLESTEROL METABOLISM; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SPINA BIFIDA; STATISTICAL ANALYSIS; BLOOD; COMPARATIVE STUDY; GENETIC POLYMORPHISM; GENETICS; NEURAL TUBE DEFECT; NEWBORN; REGISTER; RISK;

APOLIPOPROTEINS B; APOLIPOPROTEINS E; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT, NEWBORN; POLYMORPHISM, GENETIC; REGISTRIES; RISK; SPINA BIFIDA CYSTICA;

EID: 0036843112     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/tera.10097     Document Type: Article

References (30)

1. Boerwinkle E, Utermann G. 1988. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet 42:104-112.
2. Croen LA, Shaw GM, Jensvold NG, Harris JA. 1991. Birth defects monitoring in California: A resource for epidemiological research. Paediatr Perinat Epidemiol 5:423-427.
3. Croen LA, Shaw GM, Barber RC, Baker MM, Lammer EJ, Finnell RH. 2002. Apolipoprotein B and apolipoprotein E genotypes and sporadic holoprosencephaly. Am J Med Genet 108:75-77.
4. Davignon J, Gregg RE, Sing CF. 1988. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1-21.
5. Delghandi M, Thangarajah R, Nilsen M, Grimsgaard S, Bonaa KH, Tonstad S, Jorgensen L. 1999. DNA polymorphisms of the apolipoprotein B gene (XbaI, EcoRI, and MspI RFLPs) in Norwegians at risk of atherosclerosis and healthy controls. Acta Cardiol 54:215-225.
6. deKnijff P, Havekes LM. 1996. Apolipoprotein E as a risk factor for coronary heart disease: A genetic and molecular biology approach. Curr Opin Lipidol 7:59-63.
7. Farese RV Jr, Linton MF, Young SG. 1992. Apolipoprotein B gene mutations affecting cholesterol levels. J Internal Med 231:643-652.
8. Farese RV Jr, Ruland SL, Flynn LM, Stokowski RP, Young SG. 1995. Knockout of the mouse apohpoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced Hypercholesterolemia in heterozygotes. Proc Natl Acad Sci USA 92:1774-1778.
9. Frikke-Schmidt R, Nordestgaard BG, Agerholm-Larsen B, Schnorh P, Tybjaerg-Hansen A. 2000. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. J Lipid Res 41:1812-1822.
10. Fullerton SM, Clark AG, Weiss KM, Nickerson DA, Taylor SL, Stengard JH, Salomaa V, Vartiainen E, Perola M, Boerwinkle E, Sing CF. 2000. Apolipoprotein E variation at the sequence haplotype level: Implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet 67:881-900.
11. Hertz J, Willnow TE, Farese RV. 1997. Cholesterol, hedgehog and embryogenesis. Nat Genet 15:123-124.
12. Homanics GE, Smith TJ, Zhang SH, Lee D, Young SG, Maeda N. 1993. Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice. Proc Natl Acad Sci USA 90:2389-2393.
13. Homanics GE, Maeda N, Traber MG, Kayden HJ, Dehart DB, Sulik KK. 1995. Exencephaly and hydrocephaly in mice with targeted modification of the apolipoprotein B (Apob). Gene. 51:1-10.
14. Huang LS, Voyiaziakis E, Markenson DF, Sokol KA, Hayek T, Breslow JL. 1995. Apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes. J Clin Invest 96:2152-2161.
15. Hui DY, Innerarity TL, Mahley RW. 1984. Defective hepatic lipoprotein receptor binding of beta-very low-density lipoproteins from type III hyperlipoproteinemic patients. Importance of apolipoprotein E. J Biol Chem 259:860-869.
16. Knouff C, Hinsdale ME, Mezdour H, Altenburg MK, Watanabe M, Quarfordt SH, Sullivan PM, Maeda N. 1999. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J Clin Invest 103:1579-1586.
17. Lanoue L, Dehart DB, Hinsdale ME, Maeda N, Tint GS, Sulik KK. 1997. Limb, genital, CNS, and facial malformations result from gene/environment-induced cholesterol deficiency: Further evidence for a link to sonic hedgehog. Am J Med Genet 73:24-31.
18. Luc G, Bard JM, Arveiler D, Evans A, Cambou JP, Bingham A, Amouyel P, Schaffer P, Ruidavets JB, Cambien F, Fruchart JC, Ducimetiere P. 1994. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb 14:1412-1419.
19. th Edition. New York: McGraw-Hill. p 1953-1980.
20. O'Rahilly R, Muller F. 1996. Human Embryology and Teratology, 2nd Ed. New York: Wiley-Liss.
21. Pajukanta PE, Valsta LM, Aro A, Pietinen P, Helio T, Tikkanen MJ. 1996. The effects of the apolipoprotein B signal peptide (ins/del) and XbaI polymorphisms on plasma lipid responses to dietary change. Atherosclerosis 122:1-10.
22. Parker CR Jr., Carr BR, Winkel CA, Casey ML, Simpson ER, MacDonald PC. 1983. Hypercholesterolemia due to elevated low-density lipoprotein-cholesterol in newborns with anencephaly and adrenal atrophy. J Clin Endocrinol Metab 57:37-43.
23. Rantala M, Randall TT, Savolainen MJ, Friedlander Y, Kesaniemi YA. 2000. Apolipoprotein B gene polymorphisms and serum lipids: Meta-analysis of the role of genetic variation in responsiveness to diet. Am J Clin Nutr 71:713-724.
24. Roux C, Dupuis R, Horvath C, Talbot JN. 1980. Teratogenic effect of an inhibitor of cholesterol synthesis (AY 9944) in rats: Correlation with maternal cholesterolemia. J Nutr 110:2310-2312.
25. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. 1995. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6:219-226.
26. Shaw GM, Rozen R, Finnell RH, Wasserman CR, Lammer EJ. 1998. Maternal vitamin use, genetic variations of infant methylenetetrahydrofolate reductase and risk for spina bifida. Am J Epidemiol 148:30-37.
27. Sing CF, Davignon J. 1985. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37:268-285.
28. Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, Salen G. 1994. Defective cholesterol biosynthesis associated with the SmithLemli-Opitz syndrome. N Engl J Med 330:107-113.
29. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM. 1996. Apolipoprotein E alleles and risk of coronary disease. Arterioscler Thromb Vasc Biol 16:1250-1255.
30. Zivelin A, Rosenberg N, Peretz H, Amit Y, Kornbrot N, Seligsohn U. 1997. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction endonucleases. Clin Chem 43:1657-1659.